For instance, PSMC2, the most investigated one, has been found to be upregulated in various types of cancer, including gastric cancer (Liu et al., 2022), ovarian cancer (Zhu et al., 2021), and hepatocellular carcinoma (Duan et al., 2021a), promoting tumor cell proliferation and invasion. Here, PSMC2 is linked to ovarian carcinoma.